Primary study · included by 1 review

Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.

Wu 2021 · Wu Dongdong, Liu Zhengguo, Wang Yizhen, et al. · Oxidative medicine and cellular longevity · 2021

Included by

Chemoprophylaxis effect of EGCG on various digestive system diseases: a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as Wu 2021 · Reference 70

The review does not say which of its outcomes this study informs.

1 including review in total.